Leukocyte chemotactic factor 2–related amyloidosis presenting with severe jaundice and hepatic encephalopathy

Abstract

Abstract Amyloidosis is a well‐known disease with various types and subtypes. One of the most recently identified types is leukocyte chemotactic factor 2 amyloidosis (LECT 2), which was found to be common in certain ethnic backgrounds. It is suggested that the diagnosis of this type is vital to prevent any therapy‐related complications when it is erroneously diagnosed as AL amyloidosis. The clinical presentation is usually slowly progressive kidney disease and mild hepatic impairment. We report a case of LECT2 amyloidosis, which presented with severe painless cholestasis and hepatic encephalopathy alongside progressive kidney disease.

Keywords

• cholestasis
• end‐stage renal disease
• Leukocyte chemotactic factor 2 amyloidosis